CRISPR Cas9–Licensing What Can't Be Licensed

les Nouvelles - Journal of the Licensing Executives Society, Volume LIII No. 2, June 2018

9 Pages Posted: 18 Jun 2018

Date Written: April 17, 2018

Abstract

A new gene engineering technology has recently made it through the media, not only because of its technical advantages, but also because it is in the focus of an epic patent battle between two academic institutions.

The technology bears the cryptic name “CRISPR Cas9,” and allows the manipulation of genes (so called “gene editing”) with so far unseen simplicity and efficacy. Dana Carroll of the University of Utah said for this reason that CRISPR Cas9 has brought about the “democratization of gene targeting.”

Keywords: CRISPR Cas9, engineering technology, Dana Carroll university of Utah

Suggested Citation

Storz, Ulrich, CRISPR Cas9–Licensing What Can't Be Licensed (April 17, 2018). les Nouvelles - Journal of the Licensing Executives Society, Volume LIII No. 2, June 2018. Available at SSRN: https://ssrn.com/abstract=3164392

Ulrich Storz (Contact Author)

Independent ( email )

No Address Available

Register to save articles to
your library

Register

Paper statistics

Downloads
46
Abstract Views
139
PlumX Metrics